A detailed history of High Tower Advisors, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 16,325 shares of VCYT stock, worth $672,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,325
Holding current value
$672,263
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.0 - $35.25 $342,825 - $575,456
16,325 New
16,325 $555,000
Q2 2019

Aug 13, 2019

SELL
$22.1 - $28.56 $384,540 - $496,944
-17,400 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$12.0 - $25.76 $208,800 - $448,224
17,400 New
17,400 $435,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.95B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.